Sale by Helen Torley (PRESIDENT AND CEO)
20,000 shares · @ $65.35 · $1,306,940
Halozyme Therapeutics, Inc. · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $68.14
-3.0% in 1d after detection
Post-detection moves
1h
—
1d
-3.0%
3d
-0.7%
7d
-0.7%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS